CN Stock MarketDetailed Quotes
600594 Guizhou Yibai Pharmaceutical
- 2.94
- -0.02-0.68%
Market Closed Jul 29 15:00 CST
2.33BMarket Cap-267272P/E (TTM)
2.97High2.90Low61.81KlotVolume2.97Open2.96Pre Close18.13MTurnover0.78%Turnover Ratio22.44P/E (Static)791.93MShares6.0852wk High0.84P/B2.33BFloat Cap2.7652wk Low3.26Limit Up791.93MShs Float36.69Historical High2.66Limit Down2.37%Amplitude-0.11Historical Low0.07Dividend TTM2.93Avg Price29.98KlotAsk2.24%Div YieldTTM100Lot Size29.78KlotBid
Guizhou Yibai Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 15.08%764.34M | 3.93%3.05B | 6.86%2.25B | 13.27%1.52B | -1.82%664.16M | -25.33%2.93B | -25.74%2.11B | -31.74%1.34B | -42.92%676.48M | 17.10%3.92B |
| Refunds of taxes and levies | ---- | -68.27%9.13M | -68.34%9.07M | -99.58%114.98K | 5,606.86%114.98K | 4,579.15%28.78M | 1,425.66%28.63M | 128,178.11%27.3M | -86.98%2.01K | -20.84%615K |
| Cash received relating to other operating activities | -81.47%5.43M | 2.13%106.01M | -24.51%86.73M | 7.74%56.43M | 77.00%29.29M | -14.61%103.8M | 88.46%114.89M | 32.63%52.38M | -26.83%16.55M | 36.68%121.56M |
| Cash inflows from operating activities | 10.99%769.77M | 3.19%3.16B | 4.30%2.35B | 10.90%1.58B | 0.08%693.57M | -24.31%3.06B | -22.40%2.25B | -29.11%1.42B | -42.62%693.03M | 17.60%4.05B |
| Goods services cash paid | 12.22%132.08M | 10.01%574.37M | 6.47%344.72M | 14.40%252M | 16.69%117.7M | 10.95%522.12M | -2.80%323.79M | -3.24%220.28M | -14.61%100.87M | -8.56%470.6M |
| Staff behalf paid | 2.66%176.64M | -6.81%587.93M | -10.65%444.43M | -11.46%313.84M | -12.63%172.06M | -24.64%630.92M | -25.52%497.4M | -27.95%354.45M | -33.21%196.94M | -15.13%837.2M |
| All taxes paid | -48.40%42.93M | -1.89%327.39M | -2.68%250.23M | -3.51%178.56M | 1.65%83.2M | -12.29%333.71M | -14.78%257.12M | -12.17%185.05M | -4.80%81.85M | -16.47%380.48M |
| Cash paid relating to other operating activities | 23.13%322.36M | 5.08%1.29B | 11.85%963.39M | 15.10%632.88M | 0.40%261.81M | -13.58%1.23B | -18.45%861.31M | -16.88%549.86M | -11.91%260.76M | 27.42%1.42B |
| Cash outflows from operating activities | 6.18%674.01M | 2.41%2.78B | 3.26%2B | 5.17%1.38B | -0.88%634.78M | -12.69%2.72B | -17.77%1.94B | -17.73%1.31B | -19.44%640.41M | 1.24%3.11B |
| Net cash flows from operating activities | 62.86%95.75M | 9.36%377.61M | 10.88%343.16M | 76.36%202.3M | 11.74%58.79M | -63.04%345.3M | -42.65%309.49M | -72.52%114.71M | -87.25%52.62M | 154.79%934.21M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | 4,999,999,900.00%50M | 4,999,999,900.00%50M | ---- | ---- | -100.00%1 | -100.00%1 | -100.00%1 | -100.00%1 | 9,448.47%100.71M |
| Cash received from returns on investments | 127.89%10.41K | 6.18%392.78K | 6.18%392.78K | -98.18%4.57K | -98.09%4.57K | -89.03%369.93K | -88.16%369.93K | -90.36%250.9K | -90.75%239.04K | 762.18%3.37M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 9,650.00%195K | -98.07%92.24K | -97.02%87.24K | -97.51%72.17K | -99.89%2K | -27.98%4.78M | -51.94%2.93M | -10.39%2.9M | 664.08%1.82M | 142.96%6.63M |
| Cash received relating to other investing activities | --11.3M | -52.32%14.3M | ---- | ---- | ---- | --30M | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 175,167.62%11.51M | 84.34%64.79M | 1,431.42%50.48M | -97.57%76.74K | -99.68%6.57K | -68.25%35.15M | -97.00%3.3M | -97.04%3.15M | -98.01%2.06M | 62.90%110.71M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -30.98%22.16M | -59.62%130.38M | -55.33%102.92M | -59.71%73.49M | -30.43%32.1M | -27.88%322.92M | -22.79%230.41M | -2.64%182.41M | -52.18%46.14M | 13.15%447.78M |
| Cash paid to acquire investments | ---- | 150.00%50M | 150.00%50M | 150.00%50M | ---- | --20M | --20M | --20M | --20M | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --332.04M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.56M |
| Cash outflows from investing activities | -30.98%22.16M | -47.40%180.38M | -38.93%152.92M | -38.99%123.49M | -51.46%32.1M | -57.05%342.92M | -21.91%250.41M | -3.39%202.41M | -36.22%66.14M | 61.05%798.38M |
| Net cash flows from investing activities | 66.82%-10.65M | 62.44%-115.59M | 58.55%-102.44M | 38.06%-123.42M | 49.92%-32.09M | 55.24%-307.78M | -17.25%-247.11M | -93.52%-199.26M | -36,899.65%-64.08M | -60.75%-687.67M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | --80M | --80M | --80M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | --80M | ---- | ---- | ---- | ---- |
| Cash from borrowing | -11.90%148M | -18.46%730.32M | -35.67%530M | -65.76%218M | -9.34%168M | -18.18%895.7M | -9.67%823.93M | 50.38%636.65M | -33.51%185.32M | 19.32%1.09B |
| Cash received relating to other financing activities | ---- | --11.01M | --10M | --10M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -11.90%148M | -24.02%741.33M | -40.26%540M | -68.19%228M | -9.34%168M | -10.88%975.7M | -0.90%903.93M | 69.27%716.65M | -33.51%185.32M | 19.32%1.09B |
| Borrowing repayment | 74.23%149.42M | 13.82%837M | 66.34%644.32M | 15.36%193.01M | 27.39%85.76M | -47.08%735.4M | -59.74%387.35M | -65.17%167.3M | -76.60%67.32M | 29.71%1.39B |
| Dividend interest payment | -22.18%9.29M | -16.16%41.18M | -14.66%31.69M | -7.80%22.04M | 10.26%11.93M | -67.71%49.11M | -73.65%37.13M | -81.55%23.9M | -28.25%10.82M | -72.30%152.12M |
| Cash payments relating to other financing activities | 38.64%3.27M | -33.50%14.84M | -59.09%8.13M | -66.38%5.58M | -83.15%2.36M | -41.30%22.32M | -47.15%19.87M | --16.6M | --14M | --38.02M |
| Cash outflows from financing activities | 61.89%161.97M | 10.68%893.02M | 53.96%684.14M | 6.17%220.63M | 8.58%100.05M | -48.93%806.83M | -61.05%444.36M | -65.93%207.81M | -69.57%92.14M | -2.51%1.58B |
| Net cash flows from financing activities | -120.57%-13.97M | -189.83%-151.69M | -131.36%-144.14M | -98.55%7.37M | -27.07%67.95M | 134.82%168.87M | 301.02%459.57M | 372.77%508.85M | 486.42%93.17M | 31.01%-485.01M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -24.85%71.13M | -46.55%110.33M | -81.50%96.58M | -79.67%86.26M | 15.84%94.65M | 186.55%206.39M | 420.71%521.94M | 231.61%424.3M | -78.97%81.71M | 68.79%-238.47M |
| Add:Begin period cash and cash equivalents | 18.85%695.68M | 54.46%585.36M | 54.99%587.36M | 54.46%585.36M | 54.46%585.36M | -38.62%378.97M | -38.62%378.97M | -38.62%378.97M | -38.76%378.97M | -55.31%617.43M |
| End period cash equivalent | 12.77%766.81M | 18.85%695.68M | -24.08%683.93M | -16.39%671.61M | 47.61%680.01M | 54.46%585.36M | 25.53%900.91M | 7.76%803.26M | -54.27%460.67M | -38.62%378.97M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | China Securities Tiantong Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Securities Tiantong Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Securities Tiantong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg